VSee Health (NASDAQ:VSEE – Get Free Report) is one of 93 publicly-traded companies in the “Healthcare Technology” industry, but how does it contrast to its rivals? We will compare VSee Health to related companies based on the strength of its earnings, profitability, dividends, analyst recommendations, institutional ownership, risk and valuation.
Profitability
This table compares VSee Health and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| VSee Health | -92.36% | -11,636.34% | -68.62% |
| VSee Health Competitors | -749.77% | -27.84% | -15.02% |
Analyst Recommendations
This is a summary of current ratings and recommmendations for VSee Health and its rivals, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| VSee Health | 1 | 0 | 0 | 0 | 1.00 |
| VSee Health Competitors | 456 | 1539 | 2761 | 89 | 2.51 |
As a group, “Healthcare Technology” companies have a potential upside of 50.20%. Given VSee Health’s rivals stronger consensus rating and higher possible upside, analysts clearly believe VSee Health has less favorable growth aspects than its rivals.
Insider and Institutional Ownership
1.0% of VSee Health shares are held by institutional investors. Comparatively, 42.4% of shares of all “Healthcare Technology” companies are held by institutional investors. 14.9% of VSee Health shares are held by company insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Volatility & Risk
VSee Health has a beta of 0.2, indicating that its stock price is 80% less volatile than the S&P 500. Comparatively, VSee Health’s rivals have a beta of 1.11, indicating that their average stock price is 11% more volatile than the S&P 500.
Valuation & Earnings
This table compares VSee Health and its rivals top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| VSee Health | $14.46 million | -$14.71 million | -0.01 |
| VSee Health Competitors | $340.07 million | -$24.15 million | 12.15 |
VSee Health’s rivals have higher revenue, but lower earnings than VSee Health. VSee Health is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Summary
VSee Health rivals beat VSee Health on 11 of the 13 factors compared.
VSee Health Company Profile
VSee Health provides telehealth technology and virtual-care services to healthcare organizations. Its offerings include a software platform for connecting patients and clinicians through virtual visits and supporting the delivery of care remotely. The company also combines its technology with clinical services through iDoc Telehealth, which provides virtual-care support to hospitals and other healthcare providers. Together, these businesses serve organizations seeking to extend access to care and coordinate services across in-person and remote settings.
Receive News & Ratings for VSee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VSee Health and related companies with MarketBeat.com's FREE daily email newsletter.
